{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:34:49Z","timestamp":1788352489031,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Danish Council for Independent Research Medical Sciences (FSS)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.leukres.2012.07.009","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T07:21:59Z","timestamp":1344496919000},"page":"1387-1392","source":"Crossref","is-referenced-by-count":63,"title":["Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance"],"prefix":"10.1016","volume":"36","author":[{"given":"Vibe","family":"Skov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Stauffer","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Hasselbalch","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Weis","family":"Bjerrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben A.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.leukres.2012.07.009_bib0005","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"Mechanisms of disease. The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"issue":"July (7)","key":"10.1016\/j.leukres.2012.07.009_bib0010","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","article-title":"Autoimmunity and the risk of myeloproliferative neoplasms","volume":"95","author":"Kristinsson","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.07.009_bib0015","first-page":"3940","article-title":"Gene expression profiling in polycythemia vera using cDNA microarray technology","volume":"63","author":"Pellagatti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2012.07.009_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","article-title":"Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2","volume":"129","author":"Goerttler","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2012.07.009_bib0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/stemcells.2004-0131","article-title":"Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays","volume":"23","author":"Jones","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.leukres.2012.07.009_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms\u2019 tumor gene 1 (WT1)","volume":"25","author":"Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.leukres.2012.07.009_bib0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/leu.2008.357","article-title":"Molecular profile of CD34+ stem\/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia","volume":"23","author":"Catani","year":"2009","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.leukres.2012.07.009_bib0040","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-10-1092","article-title":"Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F","volume":"16","author":"Berkofsky-Fessler","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.009_bib0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"Skov","year":"2011","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.leukres.2012.07.009_bib0050","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2011.03.013","article-title":"High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis","volume":"35","author":"Hasselbalch","year":"2011","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.009_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10428194.2011.597905","article-title":"Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms","volume":"53","author":"Skov","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2012.07.009_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","author":"Skov","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2012.07.009_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.leukres.2012.07.009_bib0070","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical Bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.009_bib0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.V78.2.471.471","article-title":"Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemic cell line","volume":"78","author":"Imai","year":"1991","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2012.07.009_bib0080","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3324\/haematol.2009.007047","article-title":"The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera","volume":"94","author":"Pieri","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.07.009_bib0085","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","article-title":"Macrophage deactivation by interleukin 10","volume":"174","author":"Bogdan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2012.07.009_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0163-7258(94)90026-4","article-title":"Regulation of macrophage gene expression by T cell derived lymphokines","volume":"63","author":"Ohmori","year":"1994","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.leukres.2012.07.009_bib0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2174\/156652409788970634","article-title":"Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression","volume":"9","author":"Johnson","year":"2009","journal-title":"Curr Mol Med"},{"issue":"6","key":"10.1016\/j.leukres.2012.07.009_bib0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.leukres.2012.07.009_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/030089161109700316","article-title":"A possible mechanism of impaired NK cytotoxicity in cancer patients: down-regulation of DAP10 by TGF-beta1","volume":"97","author":"Lee","year":"2011","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.leukres.2012.07.009_bib0110","first-page":"881","article-title":"The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions","volume":"29","author":"Wada","year":"2009","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.009_bib0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-3701-1-20","article-title":"Role of dendritic cells in the induction of regulatory T cells","volume":"1","author":"Kushwah","year":"2011","journal-title":"Cell Biosci"},{"issue":"February (Suppl. B)","key":"10.1016\/j.leukres.2012.07.009_bib0120","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0828-282X(06)70982-5","article-title":"Complement activity and pharmacological inhibition in cardiovascular disease","volume":"22","author":"Th\u00e9roux","year":"2006","journal-title":"Can J Cardiol"},{"issue":"February (2)","key":"10.1016\/j.leukres.2012.07.009_bib0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.009_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3324\/haematol.2009.011866","article-title":"Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2)","volume":"95","author":"Quist-Paulsen","year":"2010","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.leukres.2012.07.009_bib0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.leukres.2012.07.009_bib0140","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","article-title":"Leukocytosis and risk stratification assessment in essential thrombocythemia","volume":"26","author":"Carobbio","year":"2008","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.leukres.2012.07.009_bib0145","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2012.07.009_bib0150","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.leu.2402124","article-title":"Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis","volume":"15","author":"Di Raimondo","year":"2001","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.009_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2009.07726.x","article-title":"Angiogenesis and vascular endothelial growth factor-\/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status","volume":"146","author":"Medinger","year":"2009","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.leukres.2012.07.009_bib0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002770050595","article-title":"Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis","volume":"78","author":"Le Bousse-Kerdil\u00e8s","year":"1999","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.leukres.2012.07.009_bib0165","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","article-title":"Role of transforming growth factor-beta in hematologic malignancies","volume":"107","author":"Dong","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.07.009_bib0170","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2004-08-3346","article-title":"The transcriptional program of terminal granulocytic differentiation","volume":"105","author":"Theilgaard-Monch","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2012.07.009_bib0175","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2011-03-340992","article-title":"Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with interferon-alpha","volume":"118","author":"Riley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.07.009_bib0180","article-title":"Reduced expression of ADAM8 is associated with myelofibrosis in myeloproliferative disease. AACR Meeting Abstract #115","volume":"47","author":"M\u00fcller","year":"2006","journal-title":"Proc Am Assoc Cancer Res"},{"issue":"10","key":"10.1016\/j.leukres.2012.07.009_bib0185","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.leukres.2012.07.009_bib0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2005.05674.x","article-title":"Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases","volume":"130","author":"Panteli","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.leukres.2012.07.009_bib0195","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/onc.2010.479","article-title":"Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F","volume":"30","author":"Boissinot","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.009_bib0200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2010.07.427","article-title":"Evaluation of the bioactive and total transforming growth factor \u03b21 levels in primary myelofibrosis","volume":"53","author":"Campanelli","year":"2011","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.leukres.2012.07.009_bib0205","doi-asserted-by":"crossref","first-page":"e15384","DOI":"10.1371\/journal.pone.0015384","article-title":"Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases","volume":"5","author":"Coudriet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2012.07.009_bib0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.leukres.2012.07.009_bib0215","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2012.07.009_bib0220","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJMe1005856","article-title":"From palliation to targeted therapy in myelofibrosis","volume":"363","author":"Vannucchi","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.leukres.2012.07.009_bib0225","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08266.x","article-title":"A pilot study of the histone-deacetylase inhibitor givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms","volume":"150","author":"Rambaldi","year":"2010","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.leukres.2012.07.009_bib0230","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"Tumor necrosis factor-alpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2012.07.009_bib0235","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3324\/haematol.2011.055392","article-title":"The JAK2 46\/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?","volume":"96","author":"Hermouet","year":"2011","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.leukres.2012.07.009_bib0240","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1182\/blood-2011-04-348755","article-title":"Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study","volume":"118","author":"Frederiksen","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.leukres.2012.07.009_bib0245","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood-2010-08-258772","article-title":"The renaissance of interferon therapy for the treatment of myeloid malignancies","volume":"117","author":"Kiladjian","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2012.07.009_bib0250","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/ehm.11.63","article-title":"A new era for IFN-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms","volume":"4","author":"Hasselbalch","year":"2011","journal-title":"Expert Rev Hematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612003086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612003086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T08:27:19Z","timestamp":1714292839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612003086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0145212612003086"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.07.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}